View Document Preview and Link Document Date: 2014-03-07 15:21:20 Open Document File Size: 477,11 KB Share Result on Facebook
Company The Carlyle Group / Synthes Inc. / Gilead Sciences Inc. / Johnson & Johnson / Shanghai Elsker Mother & Baby Co. Ltd / Janssen-Cilag International NV / DePuy Synthes Joint Reconstruction / Biosense Webster / DePuy Synthes Companies / Stop TB Partnership / MEDICAL DEVICES AND DIAGNOSTICS / Ortho-Clinical Diagnostics / / Continent Europe / / Country Japan / United States / United Kingdom / China / Ireland / / Currency USD / / Event FDA Phase / Product Issues / M&A / Reorganization / Product Release / / IndustryTerm treatment of attention deficit hyperactivity disorder / pharmaceuticals business* / oral care products / baby care products / bipolar product / skin care products / deep and productive pharmaceutical pipeline / treatment of patients with mantle cell lymphoma / energy / electrophysiology products / in-market products / launched products / social media / treatment of HIV / treatment for HIV / fixed-dose antiretroviral combination product / energy products / / MarketIndex S&P 500 / CDP Leadership / / MedicalCondition TB / HIV / multiple myeloma / mantle cell lymphoma / previously-untreated multiple myeloma / cirrhosis / compensated liver disease / severe plaque psoriasis / severely active rheumatoid arthritis / severely active ulcerative colitis / metastatic / castration-resistant prostate cancer / gastrointestinal disorders / immune-mediated inflammatory diseases / schizophrenia / diabetes / attention deficit hyperactivity disorder / refractory chronic lymphocytic leukemia/small lymphocytic lymphoma / infection / refractory mantle cell lymphoma / active psoriatic arthritis / chronic hepatitis C / tuberculosis / / MedicalTreatment chemotherapy / surgery / Catheter / drug therapy / / Organization SUSTAINABILITY Our Credo / European Medicines Agency / United Nations / U.S. Food and Drug Administration / European Commission / / Position health care sector leader / / Product VELCADE / INVEGA / CONCERTA / dexamethasone / TYLENOL / REMICADE / mercaptopurine / MOTRIN / tenofovir disoproxil fumarate / Baby TRIPLE BABY PROTECTION™ product line / PREZISTA / ACIPHEX / ribavirin / prednisone / azathioprine / rabeprazole / SIMPONI / EVARREST Fibrin Sealant Patch / STELARA / INVOKANA® (canagliflozin) / SIMPONI® (golimumab) / VELCADE® (bortezomib) / OLYSIO™ (simeprevir) / SIMPONI® ARIA / STELARA® (ustekinumab) / drug therapy / INVEGA® SUSTENNA / response / IMBRUVICA™ (ibrutinib) capsules / Baby TRIPLE BABY PROTECTION™ / / PublishedMedium the Pharmaceutical Business Review / / Technology transplantation / chemotherapy / genotype / / SocialTag 
2013 Business Highlights Johnson & Johnson delivered strong results in 2013 led by the outstanding performance in our Pharmaceutical business, the relaunch and strength of key brands in our U.S. over-the-counter (OTC) an